Go Pro
NASDAQ:SBRA

Sabra Healthcare REIT (SBRA) Stock Price, News & Analysis

Sabra Healthcare REIT logo
$21.01 +0.19 (+0.91%)
As of 04:00 PM Eastern

About Sabra Healthcare REIT Stock (NASDAQ:SBRA)

Advanced

Key Stats

Today's Range
$20.78
$21.12
50-Day Range
$18.12
$22.39
52-Week Range
$17.17
$22.77
Volume
1.64 million shs
Average Volume
2.54 million shs
Market Capitalization
$5.37 billion
P/E Ratio
80.81
Dividend Yield
5.71%
Price Target
$22.27
Consensus Rating
Moderate Buy

Company Overview

Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories. The company targets properties in key U.S. markets and select Canadian provinces where demographic trends—particularly an aging population—support demand for specialized healthcare and senior living services. This geographic and tenant diversification helps mitigate risk and supports consistent occupancy levels across its portfolio.

Headquartered in Irvine, California, Sabra Healthcare REIT was established in 2013 as a spin‐off from HCP Inc. and expanded its scale in 2019 through a merger with CareTrust REIT. Since its formation, the company has pursued disciplined capital deployment, strategic acquisitions and active asset management to enhance property values and drive sustainable cash flow growth.

Led by a management team with extensive healthcare real estate experience, Sabra continues to seek selective growth opportunities, including portfolio diversification and property development initiatives. By partnering with leading operators on new developments and renovations, the company aims to address evolving patient and resident needs while maintaining a prudent financial profile.

AI Generated. May Contain Errors.

Sabra Healthcare REIT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

SBRA MarketRank™: 

Sabra Healthcare REIT scored higher than 44% of companies evaluated by MarketBeat, and ranked 130th out of 189 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sabra Healthcare REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.54, and is based on no strong buy ratings, 7 buy ratings, 6 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Sabra Healthcare REIT is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Sabra Healthcare REIT has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Sabra Healthcare REIT's stock forecast and price target.
  • Earnings Growth

    Earnings for Sabra Healthcare REIT are expected to grow by 3.95% in the coming year, from $1.52 to $1.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sabra Healthcare REIT is 80.81, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.20.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sabra Healthcare REIT is 80.81, which means that it is trading at a more expensive P/E ratio than the Real Estate sector average P/E ratio of about 28.99.

  • Price to Earnings Growth Ratio

    Sabra Healthcare REIT has a PEG Ratio of 1.58. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Sabra Healthcare REIT has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Sabra Healthcare REIT's valuation and earnings.
  • Percentage of Shares Shorted

    9.77% of the float of Sabra Healthcare REIT has been sold short.
  • Short Interest Ratio / Days to Cover

    Sabra Healthcare REIT has a short interest ratio ("days to cover") of 8.73.
  • Change versus previous month

    Short interest in Sabra Healthcare REIT has recently increased by 0.64%, indicating that investor sentiment is decreasing.
  • Dividend Leadership

    Sabra Healthcare REIT is a leading dividend payer. It pays a dividend yield of 5.76%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Sabra Healthcare REIT does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Sabra Healthcare REIT is 461.54%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on EPS estimates, Sabra Healthcare REIT will have a dividend payout ratio of 75.95% in the coming year. This indicates that Sabra Healthcare REIT may not be able to sustain their current dividend.

  • Read more about Sabra Healthcare REIT's dividend.
  • News Sentiment

    Sabra Healthcare REIT has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Real Estate companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Sabra Healthcare REIT this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for SBRA on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Sabra Healthcare REIT to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sabra Healthcare REIT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.09% of the stock of Sabra Healthcare REIT is held by insiders.

  • Percentage Held by Institutions

    99.40% of the stock of Sabra Healthcare REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sabra Healthcare REIT's insider trading history.
Receive SBRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sabra Healthcare REIT and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SBRA Stock News Headlines

A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before August 31, pointing to a critical shift ahead for tech and AI-related stocks.tc pixel
See More Headlines

SBRA Stock Analysis - Frequently Asked Questions

Sabra Healthcare REIT's stock was trading at $18.94 at the beginning of 2026. Since then, SBRA stock has increased by 10.9% and is now trading at $21.01.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) posted its quarterly earnings results on Monday, August, 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by $0.27. The firm's quarterly revenue was up 24.7% on a year-over-year basis.
Read the conference call transcript
.

Sabra Healthcare REIT's top institutional investors include California State Teachers Retirement System (2.25%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (0.61%), Hsbc Holdings PLC (0.26%) and Wellington Management Group LLP (0.20%). Insiders that own company stock include Michael Lourenco Costa, Michael J Foster and Catherine Cusack.
View institutional ownership trends
.

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sabra Healthcare REIT investors own include NVIDIA (NVDA), AT&T (T), Meta Platforms (META), Verizon Communications (VZ), Chevron (CVX), Tesla (TSLA) and ExxonMobil (XOM).

Company Calendar

Record date for 5/29 Dividend
5/15/2026
Ex-Dividend for 5/29 Dividend
5/15/2026
Dividend Payable
5/29/2026
Last Earnings
8/03/2026
Record date for 8/31 Dividend
8/14/2026
Ex-Dividend for 8/31 Dividend
8/14/2026
Today
8/26/2026
Dividend Payable
8/31/2026
Next Earnings (Estimated)
11/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare REITs
Sub-Industry
Healthcare REITs
Current Symbol
NASDAQ:SBRA
CIK
1492298
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$19.00
Potential Upside/Downside
+6.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.54
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.26
Trailing P/E Ratio
80.81
Forward P/E Ratio
13.82
P/E Growth
1.58
Net Income
$155.61 million
Net Margins
7.61%
Pretax Margin
7.02%
Return on Equity
2.34%
Return on Assets
1.18%

Debt

Debt-to-Equity Ratio
0.95
Current Ratio
3.07
Quick Ratio
3.07

Sales & Book Value

Annual Sales
$859.56 million
Price / Sales
6.24
Cash Flow
$1.39 per share
Price / Cash Flow
15.15
Book Value
$10.77 per share
Price / Book
1.95

Miscellaneous

Outstanding Shares
255,463,000
Free Float
252,678,000
Market Cap
$5.37 billion
Optionable
Optionable
Beta
0.64

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:SBRA) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners